Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemaira in Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency (RAPID)
NCT00261833Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Mar 2006
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 4 trial of alpha1-proteinase inhibitor in alpha-1 antitrypsin deficiency (AATD), emphysema, sponsored by CSL Limited. Started Mar 2006; status: completed.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
alpha-1 antitrypsin deficiency (AATD)emphysema
Beyond the preview
Go deeper on NCT00261833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261833.